Terms: = Prostate cancer AND SLC45A3, IPCA-6, 85414, ENSG00000158715, Q96JT2, PRST, PCANAP6, IPCA6 AND Treatment
5 results:
1. Fusion transcript detection using spatial transcriptomics.
Friedrich S; Sonnhammer ELL
BMC Med Genomics; 2020 Aug; 13(1):110. PubMed ID: 32753032
[TBL] [Abstract] [Full Text] [Related]
2. slc45a3-ELK4 chimera in prostate cancer: spotlight on cis-splicing.
Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
Cancer Discov; 2012 Jul; 2(7):582-5. PubMed ID: 22787087
[TBL] [Abstract] [Full Text] [Related]
3. slc45a3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
[TBL] [Abstract] [Full Text] [Related]
4. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract] [Full Text] [Related]
5. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract] [Full Text] [Related]
